Overview

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT) and Patient Reported Outcomes in Men With Premature Ejaculation (PE)

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of IX-01 in men with lifelong premature ejaculation.
Phase:
Phase 2
Details
Lead Sponsor:
Ixchelsis Limited
Collaborators:
HealthCore-NERI
ICON plc
New England Research Institutes
Novotech (Australia) Pty Limited
PHT Corporation